Clark A T R, Guimarães da Costa V M L, Bandeira Costa L, Bezerra Cavalcanti C L, De Melo Rêgo M J B, Beltrão E I C
Universidade Federal de Pernambuco.
Eur J Histochem. 2014 May 26;58(2):2334. doi: 10.4081/ejh.2014.2334.
Polylactosamine (polyLacNAc) is a fundamental structure in glycoconjugates and it is expressed in specific cells/tissues associated with the development and carcinogenesis. β1,3-N-acetylglucosaminyl transferases (β3GnTs) play an important role in polyLacNAc synthesis, however the roles of these glycosyltransferases and their products in cancer progression are still unclear. In this sense, this work aimed to evaluate differential expression pattern of the N-acetylglucosaminyl transferases and polylactosamines in invasive and premalignant lesions of the uterus cervix. The expression of β3GnT2 and β3GnT3 were evaluated in normal (n=10) and uterine cervix lesions (n= 120) malignant (squamous carcinoma - SC) and premalignant (cervical intraepithelial neoplasia - CIN - grades 1, 2 and 3) using immunohistochemistry. Besides, lectin histochemistry with Phytolacca americana lectin (PWM) and Wheat germ agglutinin (WGA) was also carried out to observe the presence of polyLacNAc chains and N-acetylglucosamine (GlcNAc), respectively. The β3GnT3 was expressed in almost all samples (99%) and β3GnT2 was higher expressed in disease samples mainly in CIN 3, when compared with normal (P=0.002), CIN 1 (P=0.009) and CIN 2 (P=0.03). The expression of polyLacNAc was higher is SC samples, when compared with normal (P=0.03), CIN 1 (P=0.02) and CIN 3 (P=0.004), and was observed only nuclear expression in nearly 50% of the SC samples, showing a statistically significant when compared with normal (P=0.01), CIN 1 (P=0.002), CIN 2 (P=0.007) and CIN 3 (P=0.04). Deferring from transferases and polyLacNAc chains, GlcNAc (WGA ligand) reveals a gradual staining pattern decrease with the increase of the lesion degree, being more expressed in CIN 1 lesions when compared with normal (P<0.0001), CIN 2 (P<0.0001), SC (P<0.0001) and CIN 3 (P=0.0003). Our data reveals β3GnT2 and polyLacNAc may be involved in the progression of the pre-malignant lesions of human the uterine cervix. In addition, polyLacNAc expression only in the nucleus can be associated a poor prognostic in uterine lesions.
多乳糖胺(polyLacNAc)是糖缀合物中的一种基本结构,在与发育和致癌作用相关的特定细胞/组织中表达。β1,3-N-乙酰氨基葡萄糖转移酶(β3GnTs)在多乳糖胺合成中起重要作用,然而这些糖基转移酶及其产物在癌症进展中的作用仍不清楚。从这个意义上讲,这项工作旨在评估子宫颈浸润性病变和癌前病变中N-乙酰氨基葡萄糖转移酶和多乳糖胺的差异表达模式。使用免疫组织化学方法评估了β3GnT2和β3GnT3在正常子宫颈组织(n = 10)和子宫颈病变组织(n = 120)中的表达,其中病变组织包括恶性(鳞状细胞癌 - SC)和癌前病变(宫颈上皮内瘤变 - CIN - 1、2和3级)。此外,还进行了用美洲商陆凝集素(PWM)和麦胚凝集素(WGA)的凝集素组织化学,分别观察多乳糖胺链和N-乙酰氨基葡萄糖(GlcNAc)的存在情况。β3GnT3在几乎所有样本(99%)中都有表达,与正常组织(P = 0.002)、CIN 1(P = 0.009)和CIN 2(P = 0.03)相比,β3GnT2在疾病样本中,主要是在CIN 3中表达更高。与正常组织(P = 0.03)、CIN 1(P = 0.02)和CIN 3(P = 0.004)相比,多乳糖胺在SC样本中的表达更高,并且在近50%的SC样本中仅观察到核表达,与正常组织(P = 0.01)、CIN 1(P = 0.002)、CIN 2(P = 0.007)和CIN 3(P = 0.04)相比具有统计学意义。与转移酶和多乳糖胺链不同,GlcNAc(WGA配体)随着病变程度的增加呈现逐渐降低的染色模式,与正常组织(P < 0.0001)、CIN 2(P < 0.0001)、SC(P < 0.0001)和CIN 3(P = 0.0003)相比,在CIN 1病变中表达更高。我们的数据表明β3GnT2和多乳糖胺可能参与了人类子宫颈癌前病变的进展。此外,多乳糖胺仅在细胞核中的表达可能与子宫病变的不良预后相关。